CrossrefInfokarte
The effectiveness and safety of Risankizumab in pediatric patients with medically refractory inflammatory bowel disease
Journal of Pediatric Gastroenterology and Nutrition · 2026-11 · 83 (5) · 819-821
DOI: 10.1002/jpn3.70534 ↗Abstract
Kein Abstract verfügbar.
EUVIMED